Table 3.
Clinical parameters | Non intervention | Intervention | p value |
---|---|---|---|
Intention to treat analysis | |||
SBP, mmHg at final follow upa | 141.1 (138.9–143.3) | 134.6 (132.5–136.8) | 0.000 |
DBP, mmHg at final follow upa | 83.3 (82.1–84.5) | 77.6 (76.4–78.8) | 0.000 |
Difference in SBP, mmHg (Final follow up – Baseline value)a | −1.1 (−2.2 to 2.2) | −6.4 (−8.6 to −4.2) | 0.000 |
Difference in DBP, mmHg (Final follow up – Baseline value)a | −1.0 (−2.3 to 0.2) | −6.9 (−8.1 to −5.7) | 0.000 |
Per protocol analysis | |||
SBP, mmHg at final follow upa | 141.9 (139.6–144.3) | 133.6 (131.1–136.0) | 0.000 |
DBP, mmHg at final follow upa | 83.6 (82.3–84.9) | 77.2 (75.8–78.6) | 0.000 |
Difference in SBP, mmHg (Final follow up – Baseline value)a | 0.2 (−2.2 to 2.6) | −8.2 (−10.6 to −5.7) | 0.000 |
Difference in DBP, mmHg (Final follow up – Baseline value)a | −1.2 (−2.5 to 0.1) | −7.6 (−8.1 to −6.2) | 0.000 |
Adjusted for age, sex and baseline blood pressure, smoking, physical activity and alcohol consumption.